close
close

JSUMC Recognized for Excellence in Treating Heart Valve Disease

JSUMC Recognized for Excellence in Treating Heart Valve Disease

NEPTUNE — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center, licensed by the New Jersey Department of Health for open-heart surgery, have been recognized by the American College of Cardiology (ACC) for their demonstrated expertise and dedication in treating patients undergoing transcatheter valve repair and replacement procedures. They achieved Transcatheter Valve Certification based on evaluation of their teams’ ability to meet standards for multidisciplinary teaming, formalized training, shared decision-making and registry performance.

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that replaces a diseased aortic valve with an artificial valve. It is used to treat aortic stenosis, a narrowing of the aortic valve that can increase pressure on the heart and lead to heart failure. TAVR is provided to patients at only 18 hospitals in New Jersey, including Hackensack University Medical Center and Jersey Shore University Medical Center.

The ACC Transcatheter Valve Certification is a third-party review and certification process that works in conjunction with established national clinical databases to monitor patient safety and real-world outcomes related to transcatheter valve therapies. Participation in established national clinical databases such as the STS/ACC TVT Registry is required for hospitals interested in achieving Transcatheter Valve Certification.

“Hackensack Meridian Health has demonstrated its commitment to providing New Jersey with excellent cardiac care,” said Deepak L. Bhatt, MD, MPH, FACC, chair of the ACC Accreditation Management Board. “ACC Accreditation Services is proud to award Hackensack University Medical Center and Jersey Shore University Medical Center with Transcatheter Valve Certification.”

The certification uses established national clinical measures to support clinical decisions and link process improvement to patient outcomes. Hospitals that achieve Transcatheter Valve Certification learn best practices for implementing evidence-based medicine to support patient-centered decision-making and can track key performance indicators to better identify opportunities for improvement.

“Our academic medical centers with open-heart surgery programs, Jersey Shore University and Hackensack University Medical Centers, are committed to providing their patients with the best, most advanced cardiac care,” said Elizabeth A. Maiorana, MBA, MSN, RN, CCCC, vice president, Cardiovascular Care Transformation Services, Hackensack Meridian Health. “I am proud of the efforts of the cardiac teams to work together on extremely complex cases to provide high-quality, compassionate and life-saving care to every patient, regardless of their challenging circumstances.”

Earlier this year, Hackensack Meridian Health (HMH) announced a $45 million construction project at Jersey Shore University Medical Center (JSUMC), scheduled for completion in late 2024. It will create a new, dedicated cardiovascular service suite, including 10 mixed-use interventional, electrophysiology and structural heart disease labs to meet the growing needs of the community.

For more information about HMH’s cardiovascular services, visit www.HMHHasHeart.com. To schedule a CT Calcium Scoring scan or AngioScreen test, which provides early detection of heart disease risk, or for a free referral to a physician, call 844-HMH-WELL.

The ACC offers U.S. and international hospitals such as HUMC and JSUMC access to a comprehensive suite of cardiac accreditation services designed to optimize patient outcomes and improve hospital financial performance. These services address all aspects of cardiac care, including transcatheter valve therapies.